Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management

LB Lerner, KT McVary, MJ Barry, BR Bixler… - The Journal of …, 2021 - auajournals.org
Purpose: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing
proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The …

[HTML][HTML] Epidemiology and treatment modalities for the management of benign prostatic hyperplasia

SD Lokeshwar, BT Harper, E Webb… - Translational …, 2019 - ncbi.nlm.nih.gov
Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting men.
BPH can lead to a number of symptoms for patients commonly referred to as lower urinary …

Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline

HE Foster, MJ Barry, P Dahm, MC Gandhi… - The Journal of …, 2018 - auajournals.org
Purpose: Male lower urinary tract symptoms (LUTS) secondary to benign prostatic
hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL) …

Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020

JK Parsons, P Dahm, TS Köhler, LB Lerner… - The Journal of …, 2020 - auajournals.org
Purpose: The AUA Guideline panel provides evidence-based recommendations for the
surgical management of male lower urinary tract symptoms (LUTS) secondary to benign …

Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral …

AF Ray, J Powell, MJ Speakman, NT Longford… - BJU …, 2018 - Wiley Online Library
Objectives To assess the efficacy and safety of prostate artery embolization (PAE) for lower
urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and to …

[HTML][HTML] Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single …

D Abt, G Müllhaupt, L Hechelhammer, S Markart… - European Urology, 2021 - Elsevier
Background Prostatic artery embolisation (PAE) for the treatment of lower urinary tract
symptoms secondary to benign prostatic obstruction (LUTS/BPO) still remains under …

Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year …

T Bilhim, NV Costa, D Torres, LC Pinheiro… - Cardiovascular and …, 2022 - Springer
Purpose Assess long-term outcomes of prostatic artery embolization (PAE) for patients with
benign prostatic hyperplasia (BPH). Materials and Methods Single centre retrospective study …

[HTML][HTML] Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures

JVA Franco, P Tesolin, JH Jung - Prostate international, 2023 - Elsevier
Lower urinary tract symptoms due to benign prostatic hyperplasia constitute a substantial
burden, affecting the quality of life of those affected by this condition. While watchful waiting …

Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience

FC Carnevale, AM Moreira, AM de Assis, AA Antunes… - Radiology, 2020 - pubs.rsna.org
Background Long-term experience with prostatic artery embolization (PAE) for benign
prostatic hyperplasia remains limited. Purpose To evaluate the efficacy, safety, and long …

[HTML][HTML] New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: a systematic review and analysis of comparative outcomes

E Checcucci, A Veccia, S De Cillis, F Piramide… - European Urology Open …, 2021 - Elsevier
Context Benign prostatic hyperplasia (BPH) associated with lower urinary tract symptoms
(LUTS) is diagnosed in up to 80% of men during their lifetime. Several novel ultra-minimally …